Literature DB >> 27534

The effect of complement depletion on lung clearance of bacteria.

G N Gross, S R Rehm, A K Pierce.   

Abstract

We have investigated the effect of hypocomplementemia on early pulmonary clearance of four species of bacteria. The experiments were performed in an inbred animal model to minimize immunologic variability. Complement was depleted by cobra venom factor, and activity in serum was monitored with a phagocytic assay. Bacterial specific antibodies were examined by an indirect radioimmunoassay, and animals with high levels of activity were excluded from anaysis. 4 h after aerosolization with Streptococcus pneumoniae, complement-depleted animals had cleared only 75% of the initial number of organisms, whereas saline-treated controls cleared 91% (P less than 0.01). Aerosolization with Pseudomonas aeruginosa was followed at 4 h by a twofold greater growth of organisms in the complement-depleted animals (446% of original deposition) as compared to the saline-treated controls (211% of original deposition) (P less than 0.02). Clearance of Klebsiella pneumoniae and Staphylococcus aureus were similar in complement-depleted animals and saline-treated controls. These experiments suggest that hypocomplementemia predisposes to bacterial pneumonia and may explain the high incidence of pulmonary infections in patients having impaired complement activity. Our results further indicate that varying defense mechanisms may be involved with clearing the lung of differing bacterial species.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 27534      PMCID: PMC371775          DOI: 10.1172/JCI109138

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Inhibition of immune phagocytosis of Diplococcus pneumoniae by human neutrophiles with antibody against complement.

Authors:  W S JETER; A P McKEE; R J MASON
Journal:  J Immunol       Date:  1961-04       Impact factor: 5.422

2.  Relationship of functional levels of early components of complement to the H-2 complex of mice.

Authors:  M B Goldman; J N Goldman
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

3.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

4.  An abnormality of the alternate pathway of complement activation in sickle-cell disease.

Authors:  R B Johnston; S L Newman; A G Struth
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

5.  Complete absence of the third component of complement in man.

Authors:  M Ballow; J E Shira; L Harden; S Y Yang; N K Day
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Protective role of complement in experimental Escherichia coli endocarditis.

Authors:  D T Durack; P B Beeson
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

7.  Blood group isoantibody stimulation in man by feeding blood group-active bacteria.

Authors:  G F Springer; R E Horton
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

8.  Immunologic studies in pneumococcal disease.

Authors:  T H Dee; G Schiffman; M I Sottile; M W Rytel
Journal:  J Lab Clin Med       Date:  1977-06

9.  The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.

Authors:  R B Johnston; M R Klemperer; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  42 in total

1.  Complement components (C1, C2, C3, C4) in bronchial secretions after intranasal infection of guinea pigs with Mycoplasma pneumoniae: dissociation of unspecific and specific defense mechanisms.

Authors:  M Loos; H Brunner
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

2.  Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.

Authors:  Meenu Mishra; Matthew S Byrd; Susan Sergeant; Abul K Azad; Matthew R Parsek; Linda McPhail; Larry S Schlesinger; Daniel J Wozniak
Journal:  Cell Microbiol       Date:  2011-11-10       Impact factor: 3.715

3.  The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype.

Authors:  Jose Yuste; Suneeta Khandavilli; Naadir Ansari; Kairya Muttardi; Laura Ismail; C Hyams; Jeffrey Weiser; Timothy Mitchell; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

4.  The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.

Authors:  Jeremy S Brown; Tracy Hussell; Sarah M Gilliland; David W Holden; James C Paton; Michael R Ehrenstein; Mark J Walport; Marina Botto
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

5.  Opsonins in normal mouse serum for the phagocytic killing of Proteus mirabilis by murine neutrophils.

Authors:  J J Finlay-Jones; N L Hill; M F Nulsen; H Pruul; P J McDonald
Journal:  Br J Exp Pathol       Date:  1984-12

6.  The Bordetella pertussis Bps polysaccharide enhances lung colonization by conferring protection from complement-mediated killing.

Authors:  Tridib Ganguly; John B Johnson; Nancy D Kock; Griffith D Parks; Rajendar Deora
Journal:  Cell Microbiol       Date:  2014-02-13       Impact factor: 3.715

7.  Species-specific interaction of Streptococcus pneumoniae with human complement factor H.

Authors:  Ling Lu; Zhuo Ma; T Sakari Jokiranta; Adeline R Whitney; Frank R DeLeo; Jing-Ren Zhang
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  C3 promotes clearance of Klebsiella pneumoniae by A549 epithelial cells.

Authors:  Beatriz de Astorza; Guadalupe Cortés; Catalina Crespí; Carles Saus; José María Rojo; Sebastián Albertí
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia.

Authors:  Stacey L Mueller-Ortiz; Scott M Drouin; Rick A Wetsel
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.

Authors:  Catherine Hyams; Emilie Camberlein; Jonathan M Cohen; Katie Bax; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.